Gene · 38
Papers2,780
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 2,780
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Significance of monocyte infiltration in patients with gastric cancer: A combined study based on single cell sequencing and TCGA. | Front Oncol | 2022 | 36479092 | PubTator, text mining | PubMed |
| Fatty acids derived from the probiotic Lacticaseibacillus rhamnosus HA-114 suppress age-dependent neurodegeneration. | Commun Biol | 2022 | 36477191 | PubTator, text mining | PubMed |
| Proteogenomic characterization of MiT family translocation renal cell carcinoma. | Nat Commun | 2022 | 36470859 | PubTator, text mining | PubMed |
| Sarcopenia and bone health: new acquisitions for a firm liaison. | Ther Adv Musculoskelet Dis | 2022 | 36465879 | PubTator, text mining | PubMed |
| The role of noncoding RNAs in cancer lipid metabolism. | Front Oncol | 2022 | 36452489 | PubTator, text mining | PubMed |
| The Association of Ketolytic Enzymes Gene Expression Levels with Mitochondrial Activity and Content in Oral Squamous Cell Carcinoma | Asian Pac J Cancer Prev | 2022 | 36444610 | PubTator, text mining | PubMed |
| Epigenetic regulation in myocardial infarction: Non-coding RNAs and exosomal non-coding RNAs. | Front Cardiovasc Med | 2022 | 36440025 | PubTator, text mining | PubMed |
| Alteration of cholesterol distribution at the plasma membrane of cancer cells: From evidence to pathophysiological implication and promising therapy strategy. | Front Physiol | 2022 | 36439249 | PubTator, text mining | PubMed |
| Cholesterol metabolism and lipid droplet vacuoles; a potential target for the therapy of aggressive lymphoma. | J Clin Exp Hematop | 2022 | 36436934 | PubTator, text mining | PubMed |
| Molecular Mechanisms for Ketone Body Metabolism, Signaling Functions, and Therapeutic Potential in Cancer. | Nutrients | 2022 | 36432618 | PubTator, text mining | PubMed |
| Effect of Lactobacillus rhamnosus hsryfm 1301 Fermented Milk on Lipid Metabolism Disorders in High-Fat-Diet Rats. | Nutrients | 2022 | 36432537 | PubTator, text mining | PubMed |
| Nutraceutical Approaches to Dyslipidaemia: The Main Formulative Issues Preventing Efficacy. | Nutrients | 2022 | 36432457 | PubTator, text mining | PubMed |
| Essential Oils and Their Compounds as Potential Anti-Influenza Agents. | Molecules | 2022 | 36431899 | PubTator, text mining | PubMed |
| Uncovering the Mechanisms of Active Components from Toad Venom against Hepatocellular Carcinoma Using Untargeted Metabolomics. | Molecules | 2022 | 36431859 | PubTator, text mining | PubMed |
| Isosorbide Fatty Acid Diesters Have Synergistic Anti-Inflammatory Effects in Cytokine-Induced Tissue Culture Models of Atopic Dermatitis. | Int J Mol Sci | 2022 | 36430783 | PubTator, text mining | PubMed |
| Macrophage-, Dendritic-, Smooth Muscle-, Endothelium-, and Stem Cells-Derived Foam Cells in Atherosclerosis. | Int J Mol Sci | 2022 | 36430636 | PubTator, text mining | PubMed |
| Spontaneous Transformation of a p53 and Rb-Defective Human Fallopian Tube Epithelial Cell Line after Long Passage with Features of High-Grade Serous Carcinoma. | Int J Mol Sci | 2022 | 36430324 | PubTator, text mining | PubMed |
| Unveiling Human Proteome Signatures of Heart Failure with Preserved Ejection Fraction. | Biomedicines | 2022 | 36428511 | PubTator, text mining | PubMed |
| CAR-T cell combination therapy: the next revolution in cancer treatment. | Cancer Cell Int | 2022 | 36419058 | PubTator, text mining | PubMed |
| Identification of tryptophan metabolic gene-related subtypes, development of prognostic models, and characterization of tumor microenvironment infiltration in gliomas. | Front Mol Neurosci | 2022 | 36407768 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/38/papers?page=26